at 2153 has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Lu, DY; Xu, B | 1 |
| Chen, RT; Lu, DY; Xu, B; Zhang, X | 1 |
2 other study(ies) available for at 2153 and Lung Neoplasms
| Article | Year |
|---|---|
Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; China; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Razoxane; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2004 |
[Distribution of 14C labeled at dioxopiperazine or methyl morpholine group of probimane by whole body autoradiography].
Topics: Animals; Antineoplastic Agents; Autoradiography; Carbon Radioisotopes; Humans; Leukemia L1210; Lung Neoplasms; Mice; Mice, Nude; Razoxane; Tissue Distribution | 1993 |